0001567619-20-016850.txt : 20200917
0001567619-20-016850.hdr.sgml : 20200917
20200917183429
ACCESSION NUMBER: 0001567619-20-016850
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200915
FILED AS OF DATE: 20200917
DATE AS OF CHANGE: 20200917
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rosenbaum David P.
CENTRAL INDEX KEY: 0001611311
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36485
FILM NUMBER: 201182180
MAIL ADDRESS:
STREET 1: C/O ARDELYX, INC.
STREET 2: 34175 ARDENWOOD BLVD, SUITE 100
CITY: FREMONT
STATE: CA
ZIP: 94555
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARDELYX, INC.
CENTRAL INDEX KEY: 0001437402
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 34175 ARDENWOOD BLVD.
CITY: FREMONT
STATE: CA
ZIP: 94555
BUSINESS PHONE: 510-745-7047
MAIL ADDRESS:
STREET 1: 34175 ARDENWOOD BLVD.
CITY: FREMONT
STATE: CA
ZIP: 94555
FORMER COMPANY:
FORMER CONFORMED NAME: NTERYX INC
DATE OF NAME CHANGE: 20080611
4
1
doc1.xml
FORM 4
X0306
4
2020-09-15
0
0001437402
ARDELYX, INC.
ARDX
0001611311
Rosenbaum David P.
C/O ARDELYX, INC.
34175 ARDENWOOD BLVD, SUITE 200
FREMONT
CA
94555
0
1
0
0
Chief Development Officer
Common Stock
2020-09-15
4
S
0
34656
5.52
D
133047
D
Common Stock
2020-09-15
4
S
0
3470
5.5133
D
21662
I
By Wife
Common Stock
77592
I
Family Trust
Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
This transaction was executed in multiple trades in prices ranging from $5.30 to $5.86, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Reflects the adjusted total which includes the purchase of 2,062 shares on February 28, 2020 and 2,675 shares on August 31, 2020 under the Ardelyx Employee Stock Purchase Plan.
This transaction was executed in multiple trades in prices ranging from $5.30 to $5.84, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Reflects the adjusted total which includes the purchase of 2,183 shares on February 28, 2020 and 2,311 shares on August 31, 2020 under the Ardelyx Employee Stock Purchase Plan.
The shares are directly held by the Reporting Person's wife.
The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.
/s/ Elizabeth Grammer, Attorney-in-Fact for David Rosenbaum
2020-09-17